New EU Clinical Trial Regulations simplify international trials while offering t...
As Rare Disease Day is commemorated on 28 February, experts discuss the barriers...
The CHMP has recommended the approval of AbbVie's upadacitinib (Rinvoq) for trea...
A survey has shown that pharma companies have low confidence their rare disease ...
Medigene and EpimAb Biotherapeutics have signed a co-development agreement invol...
With issues in therapy delivery and a barren trial landscape, short-term chances...
The FDA has accepted Sobi’s sBLA for Gamifant for haemophagocytic lymphohistiocy...
At the American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposi...
Alltrna’s CEO Michelle Warner said that the approach allows for basket trials th...
Zevra will use the $150m to support the commercial launches of rare disease drug...
In a groundbreaking achievement, researchers at Rice University’s George R. Brow...
The CAVALIER trial, initiated by the Texas Tech University Health Sciences Cente...
In recent years, the pursuit of environmentally friendly alternatives in science...
Neuroblastoma, one of the most common solid tumors in children, poses a daunting...
The emergence of artificial intelligence (AI) technologies is revolutionizing ho...
In an extraordinary advancement in the field of dental care, researchers have un...
